Calamos Supports Greece


FDA Approves the Leqembi Drug that Slows Alzheimer’s Progress

The U.S. Food and Drug Administration on Thursday granted full approval to the Biogen and Eisai Alzheimer’s treatment Leqembi. Leqembi, also known as lecanemab, is the first drug shown to slow the progress of the disease, rather than just treating...

The Greek Doctor Behind the New Alzheimer’s Drug

A Greek, born and bred in Thessaloniki, is offering the world a wonder drug. No, his name is not Albert Bourla of Pfizer. Stelios Papadopoulos of Biogen will help millions with Alzheimer's.

New Alzheimer’s Drug Designed to Slow Disease Approved by FDA

The FDA has approved a new drug shown to slow down the early stages of Alzheimer’s despite controversy surrounding some of its more serious side effects. Lecanemab, the first drug to actively decelerate the progress of the disease, seems to...

New Alzheimer’s Drug Developed By Greek Scientists

Aduhelm, a new, completely revolutionary treatment for the dreaded disease of Alzheimer's was approved on Wednesday by the FDA.